Abstract
Elexacaftor/tezacaftor/ivacaftor (ETI) triple combination therapy has been reported to positively affect nutritional status in people with cystic fibrosis (pwCF). Besides the increase in weight, data on body composition alterations related to CFTR modulator therapy are scarce. Bioelectrical impedance analysis (BIA) has been shown fairly estimate body composition in various patient populations. We aimed to compare BIA results in children with CF at initiation and at one year of treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
